News

FDA warns Abbott ID NOW test for COVID-19 may give inaccurate results

Another COVID-19 is being investigated for faults, resulting in the United States Food and Drug Administration (FDA) to warn people that the Abbott ID NOW point-of-care test may return inaccurate, false negative results.

The warning stems from some scientific studies that have identified accuracy issues in the test. The FDA is examining whether this is due to the types of swabs used or the type of material used to transport patients’ specimens. The FDA acknowledged that no diagnostic test would be 100 percent accurate. However, the studies raising alarms have a variety of limitations themselves, including small sample sizes, potential design biases, or tests that may not have been executed according to the manufacturer’s instructions for use.

“We are still evaluating the information about inaccurate results and are in direct communications with Abbott about this important issue,” Dr. Tim Stenzel, director of the Office of In Vitro Diagnostics and Radiological Health in the FDA’s Center for Devices and Radiological Health, said. “We will continue to study the data available and are working with the company to create additional mechanisms for studying the test. This test can still be used and can correctly identify many positive cases in minutes. Negative results may need to be confirmed with a high-sensitivity authorized molecular test.”

In its examinations, the FDA is working with Abbott to analyze the information gathered. Abbott is currently working on a customer notification letter to alert users that their negative test results may not be consistent with their symptoms, signs, or actual health — and may need to be confirmed with another test. To ensure the test’s accuracy, the FDA will weigh sources and chart potential patterns or significant issues. Whatever it finds, Abbott has agreed to conduct post-market studies for its ID NOW device with at least 150 COVID-19 positive patients in various clinical settings.

Total, the FDA has so far received 15 adverse reports regarding the Abbott ID NOW device.

Chris Galford

Recent Posts

National security upgrades, pay raises and more pushed in Servicemember Quality of Life Improvement Act

Members of Congress recently paraded a mix of recommended updates to benefit military service members…

4 hours ago

Embattled TikTok in jeopardy as President Biden signs legislative ban

The ByteDance-owned TikTok faces an uphill battle in the United States after President Joe Biden…

3 days ago

Raytheon begins $115M expansion of Alabama missile integration facility

Promising to grow space for integrating and delivering on critical defense programs by more than…

3 days ago

Reward offered for Iranian nationals charged over multi-year cyber campaign against U.S. companies

In unsealing a 13-page indictment this week, the U.S. Department of Justice (DOJ) revealed charges…

4 days ago

FEND OFF Fentanyl Act included in national security supplemental

A bill targeting the illicit fentanyl supply chain, the Fentanyl Eradication and Narcotics Deterrence (FEND)…

4 days ago

Pennsylvania earns $10M federal grant to improve crime statistics reporting

In order to move the state closer to federal standards and allow reporting of local…

5 days ago

This website uses cookies.